Midi Health GLP-1 Review: Questions to Settle Before Booking, Paying and Refilling

Before booking Midi Health for GLP-1 care, ask for two things separately: the terms of the clinical visit and the details of the medication you might receive. Midi advertises no membership fees, but that does not turn its offering into one all-inclusive price. Its public documentation describes a women’s-health-focused virtual service with clinician evaluation, potential prescriptions and follow-up, while medication charges depend on the prescription and coverage. Understanding those separate decisions is more useful than comparing a single advertised starting price.

This documentary review examines public pages consulted October 19, 2026. Midi documents both brand-name GLP-1 prescribing and compounded GLP-1 or GLP-1/GIP options, including injections and sublingual drops. Important questions remain unresolved: the exact ingredients of each compounded offering, formulation-specific state availability and conflicting statements about Medicare patients. The following review turns those differences into questions you can take to Midi, your insurer and the dispensing pharmacy, without assuming that an appointment guarantees a prescription or that every advertised option is available to you.

At a glance

Visit prices: Self-pay visits are $250 for the approximately 30-minute first appointment and $150 for a 15-minute returning appointment.
Sources: [8]
Medication starting price: Compounded GLP-1 and GLP-1/GIP medication starts at $164 per four-week supply, depending on medication, format and dose; shipping and supplies are included, but visits are separate.
Sources: [7]
Prescription options: Midi documents compounded self-injections and sublingual drops, plus brand-name GLP-1 prescriptions sent to a pharmacy of choice.
Sources: [10] [7]
Geographic uncertainty: The program page advertises availability in all 50 states, but a GLP-1-specific article says the offering is not available in all 50 states.
Sources: [7] [9]
Medicare discrepancy: The pricing page welcomes Medicare beneficiaries as self-pay patients with restrictions on submitting claims; another article says Medicare patients cannot be treated even as self-pay.
Sources: [8] [6]

Start with whether Midi can serve you—not the advertised price

Midi presents itself as a virtual healthcare clinic for women and says its clinicians are board-certified and trained in women’s health. Those are provider statements, not independently verified credentials in this review. Its general terms require patients to be at least 18, or the age of majority where they live if higher, and located in a state where the service operates. Ask which clinician would provide your care and whether the specific weight-management service is available where you will attend the virtual appointment.

The geography needs a more precise answer than “nationwide.” Midi’s weight-management page says it is available in all 50 states, while a GLP-1-specific article says it is not available in all 50 states. The consulted documentation does not provide a state-by-formulation list resolving that difference. General access to Midi therefore should not be read as confirmation that a particular compounded injection, sublingual preparation or other prescription can be offered and dispensed in your state.

Medicare beneficiaries face another unresolved difference. The pricing page welcomes them as self-pay patients but says they cannot submit claims related to Midi visits, medications or associated services. A separate article, updated in December 2024, says Medicare, Medicaid and Medi-Cal patients cannot be treated even as self-pay. The pricing page also excludes Medicaid and Medi-Cal patients. Medicare beneficiaries should obtain a current answer before booking, rather than assuming that either statement settles their eligibility.

Sources: [13] [14] [7] [9] [8] [6]

Ask for a written estimate that separates the charges

Midi’s no-membership model means you pay for care and medication rather than a stated membership fee. The self-pay first visit costs $250 and lasts approximately 30 minutes; returning visits cost $150 and last 15 minutes. These are appointment prices, not treatment packages. Medication is explicitly priced separately. Before paying, ask what the appointment charge covers, whether additional services will be ordered and what happens financially if the clinician does not recommend the medication you expected.

The compounded medication offer starts at $164 per four-week supply, depending on medication, format and dose, including shipping and supplies. Four weeks is not a calendar month, and this starting figure is not a quote for every prescription. Midi also advertises programs it calls microdosing, if clinically appropriate, with weekly doses starting at $34 for eligible patients. That is a conditional medication price, not a complete weekly care cost or evidence that the two advertised prices describe the same preparation.

Brand-name GLP-1 costs depend on the drug and insurance. Midi says HSA or FSA funds can pay for visits and services, but that does not establish a particular account’s reimbursement rules. The documentation does not establish a combined total for visits, medication and laboratory work over a defined treatment period. Use these questions beyond the monthly price to request an estimate organized by charge, billing interval and what remains outside the quote.

Documented charges and the question each leaves open
Item	Published terms	Question before payment
First self-pay visit	$250; approximately 30 minutes	What additional services could be billed?
Returning self-pay visit	$150; 15 minutes	How often would visits be expected?
Compounded GLP-1 or GLP-1/GIP	Starts at $164 per four-week supply; varies by medication, format and dose; shipping and supplies included	What is the price for the exact prescription?
Microdosing offer	Weekly doses start at $34 for eligible patients, if clinically appropriate	Which preparation and other charges apply?
Brand-name GLP-1	Cost depends on drug and insurance; pharmacy of choice	What will the dispensing pharmacy charge?

Sources: [8] [11] [7]

Confirm visit coverage and drug coverage independently

Midi says it is in-network with most major insurers nationwide, but its pricing page explicitly makes coverage dependent on the individual plan. Deductibles, coinsurance and copays may still apply. During registration, Midi requests a photograph of the insurance card and says its system reports whether the patient is in-network or out-of-network. Out-of-network patients can choose a self-pay visit. That workflow helps identify a payment route; it does not make the word “covered” synonymous with a zero-dollar appointment.

Ask your plan about the actual clinical service and separately about the proposed prescription. NIDDK notes that some plans cover weight-management medicines and others do not. Midi’s acceptance of an insurer for a consultation therefore does not establish coverage for a brand-name drug, a compounded preparation or laboratory services. If a medication has not yet been selected, ask what information you will receive after the consultation to obtain a meaningful pharmacy benefit estimate.

A useful pre-appointment record includes the network answer, expected visit responsibility and the person or department that confirmed it. For medication, keep the exact product and pharmacy attached to the estimate rather than recording only “GLP-1 covered.” Our questions for the program and your health plan help separate those conversations. Midi’s public pages do not establish your personal benefits, and the Medicare discrepancy requires a provider-policy answer as well as any insurance discussion.

Sources: [8] [7] [6] [2]

Identify the exact medicine, not just the GLP-1 label

Midi documents multiple medication paths: brand-name GLP-1 prescriptions, compounded GLP-1 prescriptions and compounded GLP-1/GIP prescriptions. Its product page describes compounded self-injection and oral drops, specifying that the drops are placed under the tongue. These are sublingual drops, not tablets swallowed by mouth. The consulted pages do not unambiguously identify the active ingredient in every preparation carrying those category labels. Educational references to familiar drugs do not fill that gap.

Before comparing prices or evidence, request the proposed active ingredient, formulation, route and presentation. Ask whether it is an FDA-approved product or a compounded prescription and which pharmacy would dispense it. Midi itself states that compounded medications are not FDA approved and are not reviewed by FDA for safety, effectiveness or quality before being made available. FDA approval concerns a specific product; it is not a certification of Midi, its platform or a pharmacy.

FDA recommends compounded drugs when an individual’s medical needs cannot be met by an FDA-approved drug, with a prescription and a state-licensed pharmacy. Nonapproval alone does not prove clinical inequivalence, but it also does not establish that a compounded product shares the evidence for an approved medicine. Research on one route or formulation should not be assumed to validate Midi’s sublingual drops or advertised microdosing programs. These medicine-identification questions provide a practical starting point.

Sources: [10] [7] [11] [1] [3] [4]

Use the first visit to establish a follow-up plan

Midi’s intake questionnaire asks about health and weight history, current medications, previous treatments, risk factors and goals. The approximately 30-minute first virtual visit revisits history, symptoms, treatments and goals, then leads to a personalized care plan and follow-up recommendations. Its terms make clear that obtaining a prescription requires a consultation, a clinician’s determination that the product is appropriate and a written prescription. Booking or paying for the visit does not guarantee medication.

The documented care plan may include GLP-1 medication, laboratory orders and guidance. Midi mentions targeted tests such as blood sugar or cholesterol and describes 15-minute follow-up appointments for tracking progress and making adjustments. The pages do not establish universal laboratory requirements or a fixed follow-up cadence. Ask which tests are proposed, where they would be completed, who reviews them, what they cost and when the clinician expects the next appointment.

Midi says clinicians help manage treatment side effects. A separate article says patients prescribed personalized GLP-1 medication also receive ondansetron tablets for nausea and vomiting, but it does not establish a universal inclusion policy or price. Ask whether that statement applies to your proposed prescription and how concerns are handled between visits. NIDDK emphasizes that follow-up considers response and tolerability, not just continued payment; the practical goal is a clear clinical contact plan rather than an assumed refill schedule.

Sources: [7] [14] [10] [12] [2]

Know which organization handles each responsibility

Although its marketing uses the language of a clinic, Midi’s terms identify Midi Health, Inc. and subsidiaries as platform operators and say Midi itself is not the healthcare provider. The terms list Integrative Women’s Care PC, IWC Medical Group, P.A., IWC Medical Group KS, P.A., and Robert G. Aptekar, M.D., P.C. as medical groups accessible through the service. These groups employ or contract with healthcare professionals. Ask which medical group and clinician will be responsible for your treatment.

For prescription fulfillment, the terms name Precision Compounding Pharmacy. Midi also describes partner compounding pharmacies as licensed and “503A-accredited”; that is its wording, not an independent pharmacy verification here. The pharmacy named in platform terms does not establish which pharmacy will fill every prescription. Brand-name GLP-1 prescriptions are advertised as going to your pharmacy of choice, so the appropriate contact for dispensing questions may differ across treatment paths.

The terms also allow certain prescriptions to be sent to another selected pharmacy, with the patient responsible for paying that pharmacy directly and arranging pickup or other receipt. That provision should not be read as confirmation that every compounded formulation can be transferred anywhere. Ask about the proposed product specifically. Establish separate contacts for clinical concerns, pharmacy questions and account billing so that a problem does not get delayed while you work out who owns the next step.

Sources: [14] [11] [7]

Resolve delivery and support questions before dispatch

For the advertised compounded four-week supply, Midi includes shipping and supplies and says orders ship discreetly. That does not establish a guaranteed dispatch or arrival date. General store terms require a physical U.S. address and treat delivery dates as estimates. The consulted documentation does not establish prescription-specific cold-chain procedures or guaranteed timelines from consultation to medication receipt. Ask the dispensing pharmacy what packaging, delivery notifications and problem-reporting process apply to the exact preparation.

FDA explicitly advises patients not to use an injectable GLP-1 drug that arrives warm or with insufficient refrigeration, and to contact the provider or dispensing pharmacy. Midi’s terms also warn that not every prescription fulfilled through its pharmacies uses child-resistant packaging. Ask about the actual container and its storage instructions before delivery. FDA has reported compounded-medication measurement and administration errors; questions about instructions belong with the prescriber or pharmacist, not calculations based on a review.

The published support window in the store terms is Monday through Friday, 9 a.m. to 5 p.m. Eastern, with store@joinmidi.com and 1-888-731-8994 listed for accessibility and order assistance. This is not a promise of continuous clinical availability. Ask where to send a treatment question, whether messaging has a stated response window and who handles a delivery problem outside those hours. No guaranteed clinical response time is established by the consulted pages.

Sources: [7] [14] [1]

Find out whether your order renews—and how to stop it

No membership fee does not mean that nothing can renew automatically. Midi’s terms say certain supplements and prescription products called CustomRX may be purchased through automatically renewing subscriptions. That language does not establish that every GLP-1 prescription uses this arrangement. Before authorizing payment, ask whether your specific order is recurring, what triggers the next charge and which subscription terms apply. The general terms point to an order-specific cancellation deadline rather than establishing one universal deadline.

For applicable subscriptions, Midi says the first renewal may be charged early, and subsequent shipments may be charged and dispatched up to two days early for operational reasons. CustomRx orders also require an active, refill-eligible prescription, an eligible product, pharmacy ability to dispense and legal availability in the state. Cancellation can be requested through the account, support@joinmidi.com or 1-888-731-8994. Partially used subscription periods ordinarily are not refunded, subject to stated exceptions; stopping future charges does not promise reimbursement.

Midi also sells Daily GLP-1 Support, described as a nutritional supplement—not a weight-loss supplement or a product intended to change GLP-1 efficacy. Its listing shows conflicting subscription discounts of 20% and 10%, requiring checkout confirmation. Keep optional store purchases separate from the clinical plan. These questions before the next charge can help document renewal dates and cancellation methods; the consulted pages do not establish a specific late-cancellation or missed-appointment policy.

Sources: [11] [14] [5]

Questions & answers

Is Midi’s $164 offer the total cost of treatment?

No. It is a starting price per four-week supply for compounded GLP-1 or GLP-1/GIP medication, depending on medication, format and dose. Shipping and supplies are included. Visits are separate: self-pay pricing is $250 initially and $150 for returning visits. Laboratory costs and the exact follow-up schedule need clarification before a complete estimate is possible.

Sources: [7] [8]

Does Midi offer brand-name drugs or only compounded medication?

It documents both. Brand-name GLP-1 prescriptions are sent to the pharmacy of choice, with costs dependent on the drug and coverage. Midi also advertises compounded GLP-1 and GLP-1/GIP prescriptions. Ask which exact product is proposed, because a category label does not establish the ingredient, route, presentation or price of your prescription.

Sources: [7] [10]

Are Midi’s oral drops the same as an oral tablet?

The documented drops are sublingual: Midi says they are placed under the tongue. That is not the same presentation as a swallowed tablet. The consulted documentation does not establish that these drops share a tablet product’s formulation, approval or clinical evidence. Request the exact ingredient and formulation before making that comparison.

Sources: [10] [1]

Can a Medicare beneficiary book a self-pay Midi visit?

The public documentation conflicts. The pricing page permits self-pay Medicare patients while prohibiting submission of related claims. Another article says Medicare patients cannot be treated even as self-pay. Get current confirmation from Midi before booking. Both documents also describe restrictions on accepting Medicaid and Medi-Cal patients; do not assume self-payment overrides those restrictions.

Sources: [8] [6]

Will the first visit guarantee a prescription and ongoing refills?

No. Midi’s terms require a consultation, a clinician’s appropriateness determination and a written prescription. Its care plan may include medication, laboratory orders and guidance. For applicable CustomRx subscriptions, each fill also depends on prescription status, product eligibility, pharmacy dispensing ability and state availability. Payment or enrollment alone does not establish continuing access.

Sources: [14] [7]

How do I cancel a Midi prescription subscription?

First establish whether your order is a subscription. For applicable subscriptions, the terms allow cancellation through the online account, by emailing support@joinmidi.com or by calling 1-888-731-8994. Cancel before the deadline in your subscription terms to avoid the next charge. Early billing may apply, and cancellation does not create an ordinary refund entitlement for a partially used period.

Sources: [14]

Our assessment

Midi documents a substantive clinical pathway rather than simply a medication checkout: intake, a roughly 30-minute consultation, possible laboratory testing, individualized prescribing and shorter follow-up visits. Its published self-pay visit prices and separation of medication charges provide useful starting points for planning. The choice between brand-name and compounded options also makes product-level questions especially important. The principal documentary weaknesses are unresolved state-specific availability, conflicting Medicare statements, incomplete identification of compounded formulations and no complete treatment-period cost. Subscription rules require order-specific confirmation, not assumptions based on the absence of membership fees. Before booking, seek a clear answer on eligibility and coverage; before buying medication, obtain its exact identity, pharmacy, price and renewal terms. Those answers—not a starting price alone—will make Midi easier to evaluate against your practical needs.

Visit Midi Health’s official site ↗

This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

Midi Health GLP-1 Review: Questions to Settle Before Booking, Paying and Refilling

At a glance

01Start with whether Midi can serve you—not the advertised price

02Ask for a written estimate that separates the charges

03Confirm visit coverage and drug coverage independently

04Identify the exact medicine, not just the GLP-1 label

05Use the first visit to establish a follow-up plan

06Know which organization handles each responsibility

07Resolve delivery and support questions before dispatch

08Find out whether your order renews—and how to stop it